Docgo Inc Stock Alpha and Beta Analysis

DCGO Stock  USD 2.85  0.02  0.70%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DocGo Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in DocGo over a specified time horizon. Remember, high DocGo's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DocGo's market risk premium analysis include:
Beta
0.79
Alpha
(0.34)
Risk
4.49
Sharpe Ratio
(0.14)
Expected Return
(0.64)
Please note that although DocGo alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, DocGo did 0.34  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of DocGo Inc stock's relative risk over its benchmark. DocGo Inc has a beta of 0.79  . As returns on the market increase, DocGo's returns are expected to increase less than the market. However, during the bear market, the loss of holding DocGo is expected to be smaller as well. At this time, DocGo's Book Value Per Share is very stable compared to the past year. As of the 14th of March 2025, Tangible Book Value Per Share is likely to grow to about 2.5 M, while Enterprise Value Over EBITDA is likely to drop (0.81).

Enterprise Value

(30.45 Trillion)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out DocGo Backtesting, DocGo Valuation, DocGo Correlation, DocGo Hype Analysis, DocGo Volatility, DocGo History and analyze DocGo Performance.

DocGo Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DocGo market risk premium is the additional return an investor will receive from holding DocGo long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DocGo. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DocGo's performance over market.
α-0.34   β0.79

DocGo expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DocGo's Buy-and-hold return. Our buy-and-hold chart shows how DocGo performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

DocGo Market Price Analysis

Market price analysis indicators help investors to evaluate how DocGo stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DocGo shares will generate the highest return on investment. By understating and applying DocGo stock market price indicators, traders can identify DocGo position entry and exit signals to maximize returns.

DocGo Return and Market Media

The median price of DocGo for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 4.29 with a coefficient of variation of 16.53. The daily time series for the period is distributed with a sample standard deviation of 0.71, arithmetic mean of 4.31, and mean deviation of 0.5. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Disposition of 23088 shares by Ely Tendler of DocGo at 4.44 subject to Rule 16b-3
12/16/2024
2
Disposition of 16500 shares by Leite Etalvina of DocGo at 4.34 subject to Rule 16b-3
12/17/2024
3
Disposition of 18598 shares by Lee Bienstock of DocGo at 4.23 subject to Rule 16b-3
01/02/2025
4
DocGo Stock Hits 52-Week High at 5.05 Amid Healthcare Demand - MSN
02/04/2025
5
Subdued Growth No Barrier To DocGo Inc. With Shares Advancing 33
02/11/2025
6
DocGo Announces Upcoming Participation at TD Cowen 45th Annual Health Care Conference
02/18/2025
7
DocGo Inc Q4 2024 Earnings Report Preview What To Expect
02/26/2025
8
DocGo Announces Fourth Quarter and Full-Year 2024 Results
02/27/2025
9
DocGo Inc Q4 2024 Earnings Call Highlights Navigating Challenges and Seizing Growth ...
02/28/2025
10
All You Need to Know About Motion Acquisition Rating Upgrade to Buy
03/03/2025
11
Disposition of 59360 shares by Lee Bienstock of DocGo at 3.03 subject to Rule 16b-3
03/07/2025
12
Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3
03/13/2025

About DocGo Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DocGo or other stocks. Alpha measures the amount that position in DocGo Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Days Sales Outstanding85.34153.23124.9M
PTB Ratio2.621.921.0E-6

DocGo Upcoming Company Events

As portrayed in its financial statements, the presentation of DocGo's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DocGo's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DocGo's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DocGo. Please utilize our Beneish M Score to check the likelihood of DocGo's management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with DocGo

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out DocGo Backtesting, DocGo Valuation, DocGo Correlation, DocGo Hype Analysis, DocGo Volatility, DocGo History and analyze DocGo Performance.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
DocGo technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DocGo technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DocGo trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...